Daiichi Sankyo

Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.

Daiichi Sankyo Company, Limited
Native name
第一三共株式会社
Romanized name
Daiichi Sankyō kabushiki gaisha
Company typePublic KK
Traded as
TYO: 4568
TOPIX Large 70 Component
TOPIX 100 Component
Nikkei 225 Component
IndustryPharmaceutical
Predecessors
FoundedTokyo, Japan (2005 (2005)) (by merger)
HeadquartersDaiichi Sankyo Building A/B 3-5-1, Nihonbashi-honcho, Chūō-ku, Tokyo 103-8426, Japan
Key people
  • Sunao Manabe (Representative Director and CEO)
  • Hiroyuki Okuzawa (Representative Director, President and COO)
  • Ken Keller (President and CEO, Daiichi Sankyo, Inc.)
Products
  • Medical equipment
  • Pharmaceutical products
  • Veterinary medicines
Revenue $ 9.44 billion USD (FY 2022) (¥ 1,278 billion JPY) (FY 2022)
Net income
 $ 812 million USD (FY 2022) (¥ 109.2 billion JPY) (FY 2022)
Number of employees
17,435 (as of May 2023)
Websitehttp://www.daiichisankyo.com
Footnotes / references

Daiichi Sankyo, Inc. (DSI) began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development (Daiichi Sankyo Pharma Development), is headquartered in Basking Ridge, New Jersey.

Daiichi Sankyo Europe, GmbH (DSE), the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.

Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.